Novus Biologicals™ Complement C5 Antibody (ravulizumab) - Humanized, IgG2SA, Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Complement C5
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Research Discipline
Immunology, Innate Immunity, Stem Cell Markers
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
anaphylatoxin C5a analog, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, C5, complement C5, complement component 5, CPAMD4MGC142298, FLJ17816, FLJ17822
Immunogen
Complement C5
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone
ravulizumab
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Accession No.
P01031
Gene ID (Entrez)
727
Isotype
IgG2
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Related Products
Description
- Complement C5 Monoclonal antibody specifically detects Complement C5 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay